Viewing Study NCT04387461


Ignite Creation Date: 2025-12-24 @ 11:58 AM
Ignite Modification Date: 2026-01-25 @ 6:04 AM
Study NCT ID: NCT04387461
Status: COMPLETED
Last Update Posted: 2024-09-25
First Post: 2020-05-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of CG0070 Given in Combination With Pembrolizumab, in Non-Muscle Invasive Bladder Cancer, Unresponsive to Bacillus Calmette-Guerin
Sponsor: CG Oncology, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non Muscle Invasive Bladder Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None high-grade Ta papillary disease View
None high-grade T1 papillary disease View
None carcinoma in situ View
None Bacillus-Calmette-Guerin Unresponsive View